AMANDA GUETTLER: Open Payments
NPI 1366831935 · EUFAULA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,538 in 62 payments from 12 companies in 2025. Trend: 2023 $471 · 2024 $843 · 2025 $1,538
Food & beverage: $1,538
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $383 |
| AstraZeneca Pharmaceuticals LP | 11 | $304 |
| Lilly USA, LLC | 15 | $290 |
| ABBVIE INC. | 7 | $197 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Exact Sciences Corporation | 4 | $64 |
| Axsome Therapeutics, Inc. | 3 | $45 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
Products named: Wegovy, FARXIGA, QULIPTA, MOUNJARO, Ozempic, Kerendia, BREZTRI, CAPLYTA.
Industry payments across AL — which companies pay providers there.
